Research map: AKR1B10 as a serum marker for diagnosis and postoperative monitoring of hepatocellular carcinoma

Back to the article

Papers in this map

  1. Management of Hepatocellular Carcinoma: An Update Δσ · Jordi Bruix · 2011 · 8176 citations · Cited by this paper
  2. Circulating tumor-associated autoantibody signatures for diagnosis and prognosis in small-cell lung cancer and lung adenocarcinoma · 2026 · Related
  3. Hepatocellular carcinoma · Josep Maria Llovet · 2021 · 6739 citations · Cited by this paper
  4. High KPNA2 expression predicts poor prognosis in pathological T4 colorectal cancer by importing c-Myc into the nucleus to suppress p53-dependent p21 expression · 2026 · Related
  5. A global view of hepatocellular carcinoma: trends, risk, prevention and management · Ju Dong Yang · 2019 · 4457 citations · Cited by this paper
  6. Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial · 2026 · Related
  7. Global burden of liver disease: 2023 update · Harshad C. Devarbhavi · 2023 · 2217 citations · Cited by this paper
  8. Reactivation of DRP1 plays a functional role in resistance to MEK inhibition in pancreatic cancer cells · 2026 · Related
  9. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up · Arndt Vogel · 2018 · 1082 citations · Cited by this paper
  10. Interpreting the adverse esophageal and colorectal findings in the Cancer Risk in Vegetarians Consortium · 2026 · Related
  11. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors · Daniel Q. Huang · 2022 · 559 citations · Cited by this paper
  12. Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies · 2026 · Related
  13. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma · Joseph C. Ahn · 2020 · 353 citations · Cited by this paper
  14. Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis · 2026 · Related
  15. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma · Philip James Johnson · 2022 · 335 citations · Cited by this paper
  16. Signatures of micropeptides encoded by lncRNAs in cancer progression and metastasis · 2026 · Related
  17. Identification and Characterization of a Novel Human Aldose Reductase-like Gene · Deliang Cao · 1998 · 286 citations · Cited by this paper
  18. Can national lung cancer screening programs be implemented without exacerbating social disparities? · 2026 · Related
  19. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection · Giovanni Marasco · 2018 · 216 citations · Cited by this paper
  20. Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial · 2026 · Related
  21. Hepatocellualar Carcinoma Serum Markers · Gaetano Bertino · 2012 · 169 citations · Cited by this paper
  22. Aldo-keto Reductase Family 1 B10 Affects Fatty Acid Synthesis by Regulating the Stability of Acetyl-CoA Carboxylase-α in Breast Cancer Cells · Jun Ma · 2007 · 163 citations · Cited by this paper
  23. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma · Yeon Tae Chung · 2012 · 132 citations · Cited by this paper
  24. Risk stratification and early detection biomarkers for precision HCC screening · Yi‐Te Lee · 2022 · 123 citations · Cited by this paper
  25. AKR1B10 overexpression in breast cancer: Association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker · Jun Ma · 2012 · 117 citations · Cited by this paper
  26. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study · Charlotte E. Costentin · 2018 · 114 citations · Cited by this paper
  27. A Large‐Scale Multicenter Study Validates Aldo‐Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma · Ye Xu · 2019 · 105 citations · Cited by this paper
  28. Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy · Jiawei Shi · 2022 · 99 citations · Cited by this paper
  29. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma · Seung In Seo · 2015 · 98 citations · Cited by this paper
  30. Regulation of Gene Expression through a Transcriptional Repressor that Senses Acyl-Chain Length in Membrane Phospholipids · Harald F. Hofbauer · 2014 · 96 citations · Cited by this paper
  31. The Role of AKR1B10 in Physiology and Pathophysiology · Satoshi Endo · 2021 · 93 citations · Cited by this paper
  32. Aldo–keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels · Linlin Zhong · 2009 · 88 citations · Cited by this paper
  33. Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions · Kristina A. Matkowskyj · 2013 · 69 citations · Cited by this paper
  34. Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway · Dixian Luo · 2011 · 68 citations · Cited by this paper
  35. Impaired Self-Renewal and Increased Colitis and Dysplastic Lesions in Colonic Mucosa of AKR1B8-Deficient Mice · Yi Shen · 2014 · 64 citations · Cited by this paper
  36. AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells · Chenfei Huang · 2018 · 55 citations · Cited by this paper
  37. Knowledge representation and learning of operator clinical workflow from full-length routine fetal ultrasound scan videos · Harshita Sharma · 2021 · 48 citations · Cited by this paper
  38. Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma · Mariella Faccia · 2022 · 47 citations · Cited by this paper
  39. Biopsy for liver cancer: How to balance research needs with evidence‐based clinical practice · Morris Sherman · 2014 · 43 citations · Cited by this paper

Source: OpenAlex (CC0)